Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAT | P00750 | 19/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15941963 | 0.72 | PLAT (0.49) | PLATMEN1ALDH1A1MAPTPKM | |
| Hydrochloric Acid SCHEMBL29918467 | 0.70 | PLAT (0.48) | PLATMEN1ALDH1A1MAPTPKM | |
| Hydrochloric Acid SCHEMBL31554770 | 0.70 | PLAT (0.48) | PLATMEN1ALDH1A1MAPTPKM | |
| SCHEMBL8021529 | 0.70 | PLAT (0.42) | PLAT | |
| SCHEMBL5750605 | 0.70 | PLAT (0.38) | PLATMEN1ALDH1A1MAPTPKM | |
| Cadaverine Tartrate SCHEMBL30751761 | 0.69 | HCAR2 (0.45) | PLATALOX15 | |
| Trifluoroacetic Acid SCHEMBL5445595 | 0.69 | HCAR2 (0.48) | PLAT | |
| SCHEMBL8017108 | 0.69 | PLAT (0.38) | PLAT | |
| SCHEMBL7606761 | 0.68 | PLAT (0.41) | PLATMEN1ALDH1A1MAPTPKM | |
| SCHEMBL16845853 | 0.68 | PLAT (0.43) | PLATMEN1ALDH1A1MAPTPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000037074-A1 | MUTILIN 14-ESTER DERIVATIVES HAVING ANTIBACTERIAL ACTIVITY | SMITHKLINE BEECHAM PLC (GB) | 2000-06-29 | — | — | WO | disclosed |